The genetics of metastatic colorectal cancer has been studied for many years using
a variety of techniques with limited resolutions, which hampers the identification
of specific underlying cancer-associated genes. The introduction of high-density single
nucleotide polymorphism (SNP) arrays has allowed the identification of small regions
of chromosomal gains and losses with a resolution down to 2.5 kb. Here we used 500K
SNP mapping arrays to map the overall genetic lesions present at diagnosis in 23 primary
sporadic CRC patients with liver metastases. In order to evaluate the consistency
of the chromosomal changes identified by the SNP-arrays, interphase FISH analysis
was performed in parallel for a total of 24 chromosome regions from 20 different chromosomes.
The highest frequency of copy number (CN) losses detected corresponded to chromosomes
1p (n = 17; 74%), 8p (n = 18; 78%), 14q (n = 15; 65%), 17p (n = 19; 83%), 18 (n =
21; 91%), and 22q (n = 17; 74%), while CN gains more frequently involved chromosomes
1q (n = 10; 43%), 7 (n = 20; 87%), 8q (n = 17; 74%), 13q (n = 18; 78%), 20q (n = 20;
87%), and X (n = 13; 57%). SNP arrays allowed the identification of small (<1.3 Mb)
and extensive/large (>1.5 Mb) DNA alterations. Interestingly, several of these regions
contain cancer genes known to be involved in colorectal cancer and metastatic processes
(particularly among the amplified chromosome regions). Overall our results showed
a high degree of correlation between both methods, including the most frequently altered
regions. Moreover, four recurrent chromosomal breakpoints were identified, at chromosomes
1p12, 8p12, 17p11.2, and 20p12.1. Interestingly, detailed analysis of recurrent chromosomal
breakpoints revealed a highly prevalent breakpoint at 17p11.2, which may target genes
such as FAM27, whose role in the disease deserves further investigation.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Cancer GeneticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2010 Published by Elsevier Inc.